Literature DB >> 7325633

Antimicrobial susceptibility of intracellular Legionella pneumophila.

M A Bacheson, H M Friedman, C E Benson.   

Abstract

Minimum inhibitory concentrations, minimum bactericidal concentrations, and killing curve assays were measured after Legionella pneumophila was grown in human lung fibroblasts. Results of susceptibility testing of organisms grown intracellularly are compared with results for organisms grown by standard tube dilution methods.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7325633      PMCID: PMC181776          DOI: 10.1128/AAC.20.5.691

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  In vivo susceptibility of the Legionnaires disease bacterium to ten antimicrobial agents.

Authors:  V J Lewis; W L Thacker; C C Shepard; J E McDade
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

2.  Intracellular replication of Legionella pneumophila.

Authors:  J A Daisy; C E Benson; J McKitrick; H M Friedman
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

3.  Demonstration of the agent of Legionnaires' disease in tissue.

Authors:  F W Chandler; M D Hicklin; J A Blackmon
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

4.  Intracellular multiplication of Legionella pneumophila in cultured human embryonic lung fibroblasts.

Authors:  M C Wong; E P Ewing; C S Callaway; W L Peacock
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

5.  In vitro susceptibility of Legionella pneumophila, serogroups I-IV.

Authors:  L D Saravolatz; D J Pohlod; E L Quinn
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

6.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

7.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

8.  Susceptibility of Legionella pneumophila to twenty antimicrobial agents.

Authors:  P H Edelstein; R D Meyer
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

9.  Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease.

Authors:  D W Fraser; I Wachsmuth; C Bopp; J C Feeley; T F Tsai
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

Review 10.  Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature.

Authors:  B D Kirby; K M Snyder; R D Meyer; S M Finegold
Journal:  Medicine (Baltimore)       Date:  1980-05       Impact factor: 1.889

  10 in total
  11 in total

1.  Response of Legionella pneumophila to beta-lactam antibiotics.

Authors:  S Weisholtz; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

2.  Interaction between cyclosporin and erythromycin in a kidney transplant patient.

Authors:  M Kessler; J Louis; E Renoult; B Vigneron; P Netter
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Antimicrobial therapy of experimental Legionella micdadei pneumonia in guinea pigs.

Authors:  A W Pasculle; J N Dowling; F N Frola; D A McDevitt; M A Levi
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

4.  Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.

Authors:  A L Baltch; R P Smith; W Ritz
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

5.  WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages.

Authors:  P H Edelstein; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

6.  Antibiotic susceptibilities of Afipia felis in axenic medium and in cells.

Authors:  M Maurin; H Lepocher; D Mallet; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

7.  Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.

Authors:  A Saito; K Sawatari; Y Fukuda; M Nagasawa; H Koga; A Tomonaga; H Nakazato; K Fujita; Y Shigeno; Y Suzuyama
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

8.  Bactericidal activity of antibiotics against Legionella micdadei (Pittsburgh pneumonia agent).

Authors:  J N Dowling; R S Weyant; A W Pasculle
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

9.  Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila.

Authors:  D Havlichek; L Saravolatz; D Pohlod
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

10.  Susceptibility of Legionella spp. to imipenem and 27 other beta-lactam antibiotics.

Authors:  G Ruckdeschel; W Ehret; A Ahl
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.